Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Macimorelin
open-in-new
<h2 id="see-also">See also</h2> <ul><li><a href="/facts/List_of_growth_hormone_secretagogues/spyj9fXu">List of growth hormone secretagogues</a></li></ul> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>"Macimorelin Aeterna Zentaris". www.ema.europa.eu. 13 November 2018. <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/macimorelin-aeterna-zentaris" target="_blank">https://www.ema.europa.eu/en/medicines/human/EPAR/macimorelin-aeterna-zentaris</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>"Macrilen Prescribing Information" (PDF). Retrieved 2018-07-25. <a href="http://www.strongbridgebio.com/wp-content/uploads/macrilen-prescribing-information.pdf" target="_blank">http://www.strongbridgebio.com/wp-content/uploads/macrilen-prescribing-information.pdf</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>"Macimorelin". NCI Drug Dictionary. National Cancer Institute. <a href="https://www.cancer.gov/drugdictionary?cdrid=735530" target="_blank">https://www.cancer.gov/drugdictionary?cdrid=735530</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>Koch L (June 2013). "Growth hormone in health and disease: Novel ghrelin mimetic is safe and effective as a GH stimulation test". Nature Reviews. Endocrinology. 9 (6): 315. doi:10.1038/nrendo.2013.89. PMID 23591367. S2CID 10475359. <a href="https://doi.org/10.1038%2Fnrendo.2013.89" target="_blank">https://doi.org/10.1038%2Fnrendo.2013.89</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, et al. (June 2013). "Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency". The Journal of Clinical Endocrinology and Metabolism. 98 (6): 2422–2429. doi:10.1210/jc.2013-1157. PMC 4207947. PMID 23559086. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207947" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207947</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> <li id="fn:6"><p>WO 2001096300, Martinez J, Fehrentz JA, Guerlavais V, "Growth hormone secretagogues", published 20 December 2001, assigned to Zentaris AG <a href="https://patents.google.com/patent/WO2001096300A1/en?oq=2001096300" target="_blank">https://patents.google.com/patent/WO2001096300A1/en?oq=2001096300</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li> <li id="fn:7"><p>Broglio F, Boutignon F, Benso A, Gottero C, Prodam F, Arvat E, et al. (September 2002). "EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man". Journal of Endocrinological Investigation. 25 (8): RC26 – RC28. doi:10.1007/BF03345096. PMID 12240910. S2CID 25962252. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li> <li id="fn:8"><p>Guerlavais V, Boeglin D, Mousseaux D, Oiry C, Heitz A, Deghenghi R, et al. (March 2003). "New active series of growth hormone secretagogues". Journal of Medicinal Chemistry. 46 (7): 1191–1203. doi:10.1021/jm020985q. PMID 12646029. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li> <li id="fn:9"><p>"Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA". The Wall Street Journal. January 6, 2014. <a href="https://online.wsj.com/article/PR-CO-20140106-907640.html" target="_blank">https://online.wsj.com/article/PR-CO-20140106-907640.html</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li> <li id="fn:10"><p>Clinical trial number NCT02558829 for "Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency" at ClinicalTrials.gov <a href="https://www.clinicaltrials.gov/show/NCT02558829" target="_blank">https://www.clinicaltrials.gov/show/NCT02558829</a> <a href="#fnref:10" class="footnote-back-ref">↩</a></p></li> <li id="fn:11"><p>"Drug Approvals and Databases - Drug Trials Snapshots: Marcrilen". www.fda.gov. Retrieved 2018-07-25. <a href="https://www.fda.gov/Drugs/InformationOnDrugs/ucm590519.htm" target="_blank">https://www.fda.gov/Drugs/InformationOnDrugs/ucm590519.htm</a> <a href="#fnref:11" class="footnote-back-ref">↩</a></p></li> <li id="fn:12"><p>"FDA Approves Aeterna Zentaris' Macimorelin Growth Hormone Deficiency Test". HCPLive. 21 December 2017. Retrieved 2021-07-04. <a href="https://www.hcplive.com/view/fda-approves-aeterna-zentaris-macimorelin-growth-hormone-deficiency-test" target="_blank">https://www.hcplive.com/view/fda-approves-aeterna-zentaris-macimorelin-growth-hormone-deficiency-test</a> <a href="#fnref:12" class="footnote-back-ref">↩</a></p></li> <li id="fn:13"><p>New Drug Therapy Approvals 2017 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2018. Retrieved 16 September 2020. <a href="https://www.fda.gov/media/110526/download" target="_blank">https://www.fda.gov/media/110526/download</a> <a href="#fnref:13" class="footnote-back-ref">↩</a></p></li> </ol>